A Concise Review of Autoantibodies to Tumor-Associated Antigens for Diagnosis of Hepatocellular Carcinoma
Journal of Liver Cancer
;
: 88-91, 2015.
Artículo
en Inglés
| WPRIM
| ID: wpr-189326
ABSTRACT
Ultrasonography and tests for alpha-fetoprotein are recommended as routine surveillance tools for the early detection of hepatocellular carcinoma (HCC). However, ultrasonography is highly operator dependent and alpha-fetoprotein assays do not yield satisfactory results in diagnosing early stage HCC. Therefore, the development of more sensitive and specific tools for early HCC detection is necessary. Recent studies have shown that tumor-associated antigens (TAAs) elicited by cellular and/or humoral effectors of the immune system are attractive targets for development of diagnostic and therapeutic tools for human cancers including HCC. Most importantly, autoantibodies to TAAs can be detected prior to a clinical diagnosis of HCC. This review focuses on the important features of TAAs and the possible use of autoantibodies to TAAs as biomarkers for early HCC detection.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Autoanticuerpos
/
Biomarcadores
/
Alfa-Fetoproteínas
/
Ultrasonografía
/
Carcinoma Hepatocelular
/
Diagnóstico
/
Sistema Inmunológico
Tipo de estudio:
Estudio diagnóstico
/
Estudio de tamizaje
Límite:
Humanos
Idioma:
Inglés
Revista:
Journal of Liver Cancer
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS